Athira Pharma Inc. (ATHA)
0.53
-0.00 (-0.21%)
At close: Jan 14, 2025, 3:59 PM
0.53
-0.09%
After-hours Jan 14, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -117.67M | -95.64M | -54.85M | -19.95M | -5.16M | -5.10M |
| Depreciation & Amortization | 969.00K | 845.00K | 479.00K | 251.00K | 2.00 | n/a |
| Stock-Based Compensation | 10.62M | 10.61M | 4.62M | 633.00K | 253.00K | 196.00K |
| Other Working Capital | -840.00K | 9.84M | 1.01M | -9.05M | -23.00K | 245.00K |
| Other Non-Cash Items | -1.20M | -219.00K | 493.00K | 1.65M | 517.00K | 173.00K |
| Deferred Income Tax | n/a | n/a | n/a | -251.00K | -2 | n/a |
| Change in Working Capital | 6.53M | 11.94M | 6.16M | -6.45M | 678.00K | 245.00K |
| Operating Cash Flow | -100.75M | -72.47M | -43.10M | -24.11M | -3.71M | -4.48M |
| Capital Expenditures | -304.00K | -1.14M | -1.57M | -2.32M | n/a | n/a |
| Acquisitions | n/a | -58.80K | 2.51K | n/a | n/a | n/a |
| Purchase of Investments | -27.67M | -95.29M | -299.20M | -226.84M | -995.00K | -5.25M |
| Sales Maturities Of Investments | 123.06M | 154.09M | 296.69M | 19.05M | 2.50M | 7.25M |
| Other Investing Acitivies | n/a | 58.80K | -2.51K | 36.00K | 6.00K | 7.00K |
| Investing Cash Flow | 95.09M | 57.66M | -4.08M | -210.07M | 1.51M | 2.01M |
| Debt Repayment | n/a | n/a | n/a | 1.66M | 874.00K | 1.27M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 493.00K | 654.00K | 327.00K | 82.57M | 72.00K | 198.00K |
| Financial Cash Flow | 493.00K | 654.00K | 97.09M | 292.75M | 946.00K | 1.46M |
| Net Cash Flow | -5.17M | -14.15M | 49.91M | 58.57M | -1.26M | -1.01M |
| Free Cash Flow | -101.06M | -73.61M | -44.67M | -26.43M | -3.71M | -4.48M |